首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen
【2h】

Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen

机译:蛋氨酸脑啡肽(MENK)改善了负载抗原的骨髓来源树突状细胞(BMDC)的功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this investigation is to look at whether MENK could improve antitumor effect of CD8+T cell elicited by BMDCs. We investigated the effects of MENK on the differentiation, maturation, and functions of murine BMDC loaded with Rac-1 antigens (RG) and CTL of tumor speci□c immune response elicited by the BMDC in vitro and in vivo. The production of cytokine IL-12 and TNF-αsecreted by BMDCs in the presence of MENK was assayed with ELISA and key surface markers of CD40,CD86, CD83 and MHC-II on the BMDCs were analyzed with use of flow cytometry (FCM). In addition, the activities to induce CD8+ T cell proliferation, along with displayed cytotoxicity of the CD8+T cells(CTL) by the BMDCs after treatment with MENK were determined with use of FCM as well as MTS. Our results indicated that MENK induced phenotypic and functional maturation of BMDC loaded with RG antigen, as evidenced by higher level of expression of key surface markers and more production of cytokines. Subsequently, the BMDC activated by MENK intensified immune responses mounted by CTL, resulting in stronger antitumor activity. Our results suggest that MENK could be working as an effective immune adjuvant in vaccine preparation for cancer fight and other immune related diseases. We concluded that MENK could be a positive immune modulator in the improved functions of BMDCs loaded with antigen as well as in CD8+T cell mediated anti-tumor responses.
机译:这项研究的目的是研究MENK是否可以改善BMDC诱导的CD8 + T细胞的抗肿瘤作用。我们研究了MENK对小鼠BMDC的分化,成熟和功能的影响,所述小鼠BMDC含有Rac-1抗原(RG)和CTL在体外和体内引起的BMDC引起的肿瘤特异性免疫反应。用ELISA检测在存在MENK的情况下BMDC分泌的细胞因子IL-12和TNF-α的产生,并用流式细胞术(FCM)分析CDDC上CD40,CD86,CD83和MHC-II的关键表面标志。另外,使用FCM和MTS测定了用MENK处理后,BMDCs诱导CD8 + T细胞增殖的活性以及对CD8 + T细胞(CTL)显示的细胞毒性。我们的结果表明,MENK诱导了带有RG抗原的BMDC的表型和功能成熟,关键表面标志物的更高表达水平和更多细胞因子产生证明了这一点。随后,由MENK激活的BMDC增强了CTL产生的免疫反应,从而导致更强的抗肿瘤活性。我们的研究结果表明,MENK可以在抗癌和其他免疫相关疾病的疫苗制备中作为有效的免疫佐剂。我们得出的结论是,MENK可能是负载抗原的BMDC的功能改善以及CD8 + T细胞介导的抗肿瘤反应中的阳性免疫调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号